Keywords = PD-L1
Number of Articles: 6
1. NFATc1 is Suppressed in Tumor Microenvironment of Hodgkin Lymphoma

Volume 22, Issue 6, June 2021, Pages 1943-1948

Krisna Murti; Neti Neti; Nyiayu Fauziah Kurniawati; Ika Kartika; Riana Sari Puspita Rasyid; Zen Hafy


2. Evaluating the Possible Association between PD-1 (Rs11568821, Rs2227981, Rs2227982) and PD-L1 (Rs4143815, Rs2890658) Polymorphisms and Susceptibility to Breast Cancer in a Sample of Southeast Iranian Women

Volume 21, Issue 10, October 2020, Pages 3115-3123

Shima Karami; Hedieh Sattarifard; Mohammad Kiumarsi; Sahel Sarabandi; Mohsen Taheri; Mohammad Hashemi; Gholamreza Bahari; Saeid Ghavami


3. Increased CD8 Tumor Infiltrating Lymphocytes in Colorectal Cancer Microenvironment Supports an Adaptive Immune Resistance Mechanism of PD-L1 Expression

Volume 20, Issue 11, November 2019, Pages 3421-3427

Aru W Sudoyo; Antonius N Kurniawan; Gita D Kusumo; Teguh P Putra; Fritzie A Rexana; Muhammad Yunus; Akterono D Budiyati; Dicky Kurniawan; Andi Utama; Ahmad R Utomo


4. Programmed Death Ligand 1; An Immunotarget for Renal Cell Carcinoma

Volume 20, Issue 10, October 2019, Pages 2951-2957

Deepika Chandrasekaran; Sandhya Sundaram; Kadhiresan N; Padmavathi R


5. Upregulation of Galectin-9 and PD-L1 Immune Checkpoints Molecules in Patients with Chronic Lymphocytic Leukemia

Volume 18, Issue 8, August 2017, Pages 2269-2274

Saeid Taghiloo; Esmaeil Allahmoradi; Reza Ebadi; Mohsen Tehrani; Zahra Hosseini-Khah; Ghasem Janbabai; Ramin Shekarriz; Hossein Asgarian-Omran


6. Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma

Volume 18, Issue 6, June 2017, Pages 1671-1674

Sakkarn Sangkhamanon; Piangpen Jongpairat; Aumkhae Sookprasert; Kosin Wirasorn; Attapol Titapun; Ake Pugkhem; Piti Ungareevittaya; Jarin Chindaprasirt